2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation.

      Cell
      Amino Acid Sequence, Base Sequence, Binding Sites, DNA Mutational Analysis, In Vitro Techniques, Molecular Sequence Data, Oligonucleotides, chemistry, Oncogene Proteins, Viral, genetics, metabolism, Papillomaviridae, pathogenicity, Protein Binding, Recombinant Fusion Proteins, Repressor Proteins, Structure-Activity Relationship, Trans-Activators, Transcription, Genetic, Transcriptional Activation, Tumor Suppressor Protein p53

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Human papillomavirus (HPV) types 16 and 18 appear to play a role in the development of ano-genital malignancies, whereas HPV 6 and 11 are usually associated with benign lesions. One HPV16 oncoprotein, E6, complexes with and promotes degradation of the cellular tumor suppressor p53. Here we show that E6 proteins of both oncogenic and benign HPV types associate in vitro with p53, but binding by E6 proteins of benign HPV types cannot target p53 for degradation. A C-terminal region of E6 conserved among all HPV types is important for p53 binding. However, N-terminal sequences of E6 conserved only between oncogenic HPV types are necessary to direct p53 degradation. p53 binding by E6 appears necessary but not sufficient for this activity. All E6 proteins tested showed comparable transcriptional trans-activating activity, a property that does not require the ability to bind or direct degradation of p53.

          Related collections

          Author and article information

          Comments

          Comment on this article